Sera Prognostics (SERA) Current Assets (2020 - 2026)
Sera Prognostics (SERA) posted Current Assets of $49.7 million for Q1 2026, up 21.97% on a QoQ basis from $40.8 million in Q4 2025, and up 5.17% year-over-year from $47.3 million in Q1 2025.
Sera Prognostics (SERA) Current Assets (2020 - 2026) Analysis & Trends
Sera Prognostics' Current Assets history runs 7 years deep, the most recent figure standing at $49.7 million for Q1 2026.
- Quarterly Current Assets rose 5.17% year-over-year to $49.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.7 million (up 5.17% YoY) and the FY2025 annual result came in at $40.8 million, down 14.35% from the prior year.
- Current Assets was $49.7 million for Q1 2026 at Sera Prognostics, up from $40.8 million in the prior quarter.
- Across five years, Current Assets topped out at $109.5 million in Q1 2022 and bottomed at $40.8 million in Q4 2025.
- A 5-year average of $63.0 million and a median of $51.5 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets gained 18.26% — and 2023, when it tumbled 47.66%.
- Sera Prognostics' Current Assets stood at $90.1 million in 2022, then slumped by 31.93% to $61.3 million in 2023, then fell by 22.4% to $47.6 million in 2024, then dropped by 14.35% to $40.8 million in 2025, then grew by 21.97% to $49.7 million in 2026.
- Business Quant data shows SERA's Current Assets at $49.7 million in Q1 2026, $40.8 million in Q4 2025, and $44.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 132.07 Bn | 129.19 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 111.38 Bn | 102.16 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 68.98 Bn | 67.53 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 28.91 Bn | 27.80 Bn | 750.30 Mn | 4.33 Bn |
| 7 | GE HealthCare Technologies | 28.83 Bn | 26.55 Bn | 1.98 Bn | 10.43 Bn |
| 8 | Smith & Nephew | 28.10 Bn | 27.52 Bn | - | 4.10 Bn |
| 9 | Koninklijke Philips | 24.30 Bn | 21.26 Bn | 2.01 Bn | 11.13 Bn |
| 10 | Sera Prognostics | 100.52 Mn | 100.52 Mn | -28,000.00 | 49.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.73 Mn |
| Dec 31, 2025 | 40.77 Mn |
| Sep 30, 2025 | 44.49 Mn |
| Jun 30, 2025 | 40.87 Mn |
| Mar 31, 2025 | 47.28 Mn |
| Dec 31, 2024 | 47.60 Mn |
| Sep 30, 2024 | 51.11 Mn |
| Jun 30, 2024 | 51.54 Mn |
| Mar 31, 2024 | 53.85 Mn |
| Dec 31, 2023 | 61.34 Mn |
| Sep 30, 2023 | 47.55 Mn |
| Jun 30, 2023 | 64.43 Mn |
| Mar 31, 2023 | 72.11 Mn |
| Dec 31, 2022 | 90.13 Mn |
| Sep 30, 2022 | 90.84 Mn |
| Jun 30, 2022 | 108.05 Mn |
| Mar 31, 2022 | 109.47 Mn |
| Dec 31, 2021 | 110.25 Mn |
| Sep 30, 2021 | 122.34 Mn |
| Jun 30, 2021 | 91.37 Mn |